Back to top
more

QIAGEN (QGEN)

(Delayed Data from NYSE)

$43.36 USD

43.36
1,538,228

-0.29 (-0.66%)

Updated Aug 26, 2026 04:00 PM ET

After-Market: $43.34 -0.02 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (157 out of 247)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

LabCorp (LH) Q1 Earnings Surpass Estimates, Revenues Miss

by Zacks Equity Research

LabCorp (LH) reports better-than-expected earnings for the first quarter, with robust sales within the Drug Development arm driving the top line.

Zacks Equity Research

Hologic (HOLX) Q2 Earnings Surpass Estimates, 2022 View Up

by Zacks Equity Research

Hologic's (HOLX) second-quarter 2022 revenues decline year over year primarily due to lower COVID-19 assay sales compared to the prior year.

Zacks Equity Research

Amedisys (AMED) Q1 Earnings Surpass Estimates, Margins Down

by Zacks Equity Research

Impressive performance by the Home Health and Hospice segments drove Amedisys' (AMED) revenues in the first quarter.

Zacks Equity Research

Align Technology (ALGN) Q1 Earnings Lag Estimates, Margins Fall

by Zacks Equity Research

Robust Clear Aligner case volume growth and increased uptake of the iTero Element 5D Plus are driving Align Technology's (ALGN) first-quarter top line.

Zacks Equity Research

Abiomed (ABMD) Q4 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Abiomed's (ABMD) strength in Impella product revenues drives its Q4 top line.

Zacks Equity Research

Qiagen (QGEN) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Qiagen (QGEN) delivered earnings and revenue surprises of 12.68% and 6.52%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Ecolab's (ECL) Q1 Earnings in Line, Revenues Beat Estimates

by Zacks Equity Research

Ecolab's (ECL) robust performance across all of its segments drives its Q1 sales despite business challenges.

Zacks Equity Research

Quidel (QDEL) to Report Q1 Earnings: What's in the Offing?

by Zacks Equity Research

Quidel's (QDEL) first-quarter results are likely to reflect continued strength across its SARS-related products.

Zacks Equity Research

Catalent (CTLT) to Report Q3 Earnings: What's in the Cards?

by Zacks Equity Research

Catalent's (CTLT) Q3 results are likely to have been driven by robust segmental performances.

Zacks Equity Research

QGEN or ILMN: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

QGEN vs. ILMN: Which Stock Is the Better Value Option?